High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study.

MLA

Ming-Lung Yu, et al. “High versus Standard Doses Interferon-Alpha in the Treatment of Naïve Chronic Hepatitis C Patients in Taiwan: A 10-Year Cohort Study.” BMC Infectious Diseases, vol. 5, no. 1, Jan. 2005, pp. 27–10. EBSCOhost, https://doi.org/10.1186/1471-2334-5-27.

APA

Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, Li-Po Lee, Ming-Yen Hsieh, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang, Jung-Fa Tsai, Wen-Yu Chang, & Wan-Long Chuang. (2005). High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study. BMC Infectious Diseases, 5(1), 27–10. https://doi.org/10.1186/1471-2334-5-27

Chicago

Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, Li-Po Lee, Ming-Yen Hsieh, Zu-Yau Lin, Ming-Yuh Hsieh, et al. 2005. “High versus Standard Doses Interferon-Alpha in the Treatment of Naïve Chronic Hepatitis C Patients in Taiwan: A 10-Year Cohort Study.” BMC Infectious Diseases 5 (1): 27–10. doi:10.1186/1471-2334-5-27.